Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03940352 |
| Title | HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | ITA | FIN | ESP | DEU | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Duke University Medical Center . | Durham | North Carolina | 27710 | United States | Details | |
| Novartis Investigative Site | Melbourne | Victoria | 3004 | Australia | Details | |
| Novartis Investigative Site | Helsinki | FIN 00290 | Finland | Details | ||
| Novartis Investigative Site | Heidelberg | 69120 | Germany | Details | ||
| Novartis Investigative Site | Wuerzburg | 97080 | Germany | Details | ||
| Novartis Investigative Site | Milano | MI | 20132 | Italy | Details | |
| Novartis Investigative Site | Roma | RM | 00161 | Italy | Details | |
| Novartis Investigative Site | Singapore | 119228 | Singapore | Details | ||
| Novartis Investigative Site | Madrid | 28041 | Spain | Details |